Analysis of Serum Micro-RNAs as potential biomarker in chronic obstructive pulmonary disease

Experimental Lung Research

Volumn 38, Issue 6, 2012, Pages 286-294

  Akbas, Fahri ^a   Coskunpinar, Ender ^b   Aynaci, Engin ^c   Müsteri Oltulu, Yasemin ^b   Yildiz, Pinar ^c  

^a FATIH UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Yedikule Chest Diseases and Chest Surgery Training and Research Hospital   (Turkey)

Author keywords

Gene expression; Molecular marker; Quantitative RT PCR

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 20A; MICRORNA 28; MICRORNA 34C; MICRORNA 3P; MICRORNA 5P; MICRORNA 7; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; LUNG PARENCHYMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UPREGULATION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UP-REGULATION;

EID: 84862855868     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2012.689088     Document Type: Article

References (51)

1. Oglesby IK, McElvaney NG, Greene CM: MicroRNAs in inflammatory lung disease-master regulators or target practice? Respir Res. 2010;11:148
2. Adcock IM, Caramori G, Barnes PJ: Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81:265-284
3. Pauwels RA, Buist AS, Calverley P, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757
5. Punturieri A, Szabo E, Croxton TL, Shapiro SD, Dubinett SM: Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. J Natl Cancer Inst. 2009;101:554
6. Ben-Zaken Cohen S, Pare PD, Man SF, Sin DD: COPD and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med. 2007;176:113-12
7. He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522-331
8. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RHA, Cuppen E: Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120:21-24
9. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al.: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006
10. Liu Z, Li G, Wei S, Niu J, El Naggar A: Genetic variants in selected pre microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010;116:4753-4760
11. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA: Rapid changes in microRNA-146a expression negatively regulate the IL-1-induced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008;180:5689
12. Stanczyk J, Pedrioli DML, Brentano F, Sanchez Pernaute O, Kolling C, Gay RE, et al.: Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58:1001-1009
13. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, et al.: Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis. J Clin Immunol. 2011;31:69-73
14. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, et al.: A fivemicroRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47:784-791
15. Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C, et al.: Identification of ten serum microRNAs from a genome wide serum microRNA expression profile as novel non invasive biomarkers for non small cell lung cancer diagnosis. Int J Cancer. 2011. Online ahead of print. DOI: 10.1002/ijc.26177
16. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo L, et al.: The oncogenetic role of MicroRNA-31 as a potential biomarker in esophageal squamous cell carcinoma. Clin Sci. 2011;121: 437-447
17. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S: A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS ONE. 2010;5:e13735
18. Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, et al.: Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma. PLoS ONE. 2011;6:e18232
19. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, et al.: Diagnostic and prognostic impact of six circulatingMicroRNAs in acute coronary syndrome. JMol Cell Cardiol. 2011;51:872-875
20. Kerr TA, Korenblat KM, Davidson NO: microRNAs and liver disease. Transl Res. 2011;157:241-252
21. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532
22. SuiW, Dai Y, Huang YS, Lan H, Yan Q, Huang H:Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transplant Immunol. 2008;19:81-85
23. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods. 2001;25:402-408
24. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, et al.: COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD J Chron Obstruct Pulm Dis. 2008;5:235-256
25. Ambros V: The functions of animal microRNAs. Nature. 2004;431:350-355
26. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al.: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99:15524
27. Lum A,Wang B, Li L, Channa N, Bartha G,Wabl M: Retroviral activation of the mir-106a microRNA cistron in T lymphoma. Retrovirology. 2007;4:5
28. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al.: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.Mol Cell. 2007;26:745-752
29. Jardim MJ, Fry RC, Jaspers I, Dailey L, Diaz-Sanchez D: Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect. 2009;117:1745
30. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S: Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 2009;23: 806
31. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, et al.:MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A. 2009;106:2319
32. Izzotti A, Calin GA, Steele VE, Croce CM, De Flora S: Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J. 2009;23:3243
33. Ueda T, Volinia S, OkumuraH, ShimizuM, Taccioli C, Rossi S, et al.: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11:136-146
34. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proce Natl Acad Sci U S A. 2008;105:10513
35. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al.: Detection of elevated levels of tumour associated microRNAs in serum of patients with diffuse large B cell lymphoma. Br J Haematol. 2008;141:672-675
36. Kanemaru H, Fukushima S, Yamashita J, Honda N, Masuguchi ROAKS, Ishihara T, et al.: The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci. 2011;61:187-193
37. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, Lenhof HP, Meese E: Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer. 2011;74:41-47
38. Provinciali M, Cardelli M, Marchegiani F: Inflammation, chronic obstructive pulmonary disease and aging. Curr Opin Pulm Med 2001;17(S1):S3-10
39. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WDC, Moxham J, Hopkinson NS, Polkey MI, Kemp PR: Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax. 2011;67:26-34
40. Oglesby IK, McElvaney NG, Greene CM: MicroRNAs in inflammatory lung disease-master regulators or target practice? Respir Res. 2010;11:148
41. Adcock IM, Caramori G, Barnes PJ: Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81:265-284
42. Li LJ, Gao LB, LvML, Dong W, Su XW, LiangWB, Zhang L: Association between SNPs in pre-miRNA and risk of chronic obstructive pulmonary disease. Clin Biochem. 2011;44:813-6
43. Nana-Sinkam SP, Karsies T, Riscili B, Ezzie M, Piper M: xxx. Exp Rev Respir Med. 2009;3:373-385
44. Crawford M, Batte K, Yu L, Wu X, Nuovo GJ, Marsh CB, et al.: MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun. 2009;388:483-489
45. Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, et al.: Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol. 2008;173:856
46. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, et al.: p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol. 2007;17: 1298-1307
47. Schultz J, Lorenz P, Gross G, Ibrahim S, Kunz M: MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 2008;18:549-557
48. Leite KRM, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Saudo A, et al., eds.: Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol. 2011;29:265-9
49. Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, et al.: MiRNA expression in urothelial carcinomas: important roles of miR 10a, miR 222, miR 125b, miR 7 and miR 452 for tumor stage and metastasis, and frequent homozygous losses of miR 31. Int J Cancer. 2009;124:2236-2242
50. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS, Leedman PJ: Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem. 2009;284:5731
51. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, et al.: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 2008;68: 3566